CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer - Wikidata - wikimedia - TriplyDB

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

http://www.wikidata.org/entity/Q28530421

about

Molecular biology of lung cancer: clinical implications Role of cell cycle regulators in lung carcinogenesis Integrity of the LXXLL motif in Stat6 is required for the inhibition of breast cancer cell growth and enhancement of differentiation in the context of progesterone.Bioinformatic screening of human ESTs for differentially expressed genes in normal and tumor tissues.Knocking down CDK4 mediates the elevation of let-7c suppressing cell growth in nasopharyngeal carcinoma.Integrative genome analysis reveals an oncomir/oncogene cluster regulating glioblastoma survivorship.Discovery of co-occurring driver pathways in cancer tRNA modifying enzymes, NSUN2 and METTL1, determine sensitivity to 5-fluorouracil in HeLa cells Amplified and homozygously deleted genes in glioblastoma: impact on gene expression levels Identification of the NEDD4L gene as a prognostic marker by integrated microarray analysis of copy number and gene expression profiling in non-small cell lung cancer.Elevated expression of CDK4 in lung cancer.Novel candidate key drivers in the integrative network of genes, microRNAs, methylations, and copy number variations in squamous cell lung carcinoma.Recombinant human alpha fetoprotein synergistically potentiates the anti-cancer effects of 1'-S-1'-acetoxychavicol acetate when used as a complex against human tumours harbouring AFP-receptors.De novo discovery of mutated driver pathways in cancer Heat shock protein 90 inhibition in lung cancer.CDK4 and miR-15a comprise an abnormal automodulatory feedback loop stimulating the pathogenesis and inducing chemotherapy resistance in nasopharyngeal carcinoma.Increased HOX C13 expression in metastatic melanoma progression.Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer.Highly parallel identification of essential genes in cancer cells.Pleiotropy between genetic markers of obesity and risk of prostate cancer.Disrupting the PIKE-A/Akt interaction inhibits glioblastoma cell survival, migration, invasion and colony formation.Hyperexpression of HOXC13, located in the 12q13 chromosomal region, in well‑differentiated and dedifferentiated human liposarcomas.Aberrant expression of posterior HOX genes in well differentiated histotypes of thyroid cancers Prognostic and predictive value of cell cycle deregulation in non-small-cell lung cancer.Elucidation of the genetic and epigenetic landscape alterations in RNA binding proteins in glioblastoma.miR-16 induction after CDK4 knockdown is mediated by c-Myc suppression and inhibits cell growth as well as sensitizes nasopharyngeal carcinoma cells to chemotherapy.The genomic dynamics during progression of lung adenocarcinomas Identification of HERC5 and its potential role in NSCLC progression.CDK4 in lung, and head and neck cancers in old age: evaluation as a biomarker.DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk.Co-amplification of phosphoinositide 3-kinase enhancer A and cyclin-dependent kinase 4 triggers glioblastoma progression.Nuclear expression of CDK4 correlates with disease progression and poor prognosis in human nasopharyngeal carcinoma.Opposite roles of FOXA1 and NKX2-1 in lung cancer progression.Targeting cell cycle kinases and kinesins in anticancer drug development.Cyclin-dependent kinase 4 overexpression is mostly independent of gene amplification and constitutes an independent prognosticator for nasopharyngeal carcinoma.Integrated Omic analysis of lung cancer reveals metabolism proteome signatures with prognostic impact Somatic inactivating PTPRJ mutations and dysregulated pathways identified in canine malignant melanoma by integrated comparative genomic analysis

P2860

Q24610335-69FCC988-0686-48E5-9E4C-ED586A307A75 Q28394676-4E65991C-1C0F-4DFF-B3C0-FBFFCFBCC5A6 Q30578094-AEB737BF-F1FB-443A-92FB-7A3688619F5A Q33241205-36BE0991-254D-47DD-878D-703A08B4CC14 Q33583605-86E3E113-B920-4205-965E-3144F72CFAE9 Q33719798-25483A12-EA86-49C4-B84C-74E5CA172AAF Q34048409-333FBF6E-1679-4B80-98C3-7CCCAAFB3014 Q34214788-ED2368AC-CB9F-43A7-AFBB-E7EF9EA80128 Q34430791-9B09DF73-4B5C-4624-93E7-11E738CC5A74 Q34787147-5B510402-1BE7-49E5-86F5-7E73881EB114 Q34980269-2FF0CF0B-9A43-49CE-955A-FE6E1B7AED77 Q35156742-B2E9B5FD-595E-4911-A6FF-D5E5F9830345 Q35687188-F8839CC2-BB3E-4ECF-A686-20838C85A3B8 Q35694415-368E67B7-EB94-413D-8FBE-6CBF55A60EC9 Q35762499-1A4A425A-2108-4305-B630-831B7FD5B911 Q35963331-241CE4AE-41F2-4D59-940A-B92CA650F582 Q36338556-FAAD36ED-BC69-4D6F-A22D-EB5BE45E20A1 Q36448676-BA3701F4-E9A4-4894-BABD-DD51E1A30AA4 Q37068513-A014C86D-CED1-4B8B-91ED-66F2E5BFD586 Q37161336-7C5FA6D1-E4C6-467C-871C-EBAA36B738BF Q37254681-900C1718-B53C-40A3-9403-DE3384FC43FD Q37341266-90546F4A-5B80-4BA7-90DC-9CD52F460AD1 Q37375359-0BFCA8BA-4306-4152-A246-E6C37DE8071B Q37996270-6385B8C0-CE1C-46BB-9674-FF2DCAAD105D Q38723760-6CFD9F36-BBC4-4C89-9FD3-4162DB17176C Q38834438-2484A87F-1C4E-450B-8CCF-FC775DEE3BA3 Q38851468-7A2AF9DA-28EA-4321-A1EA-1F5C2C191C65 Q38944168-1493796E-B4EA-4F73-9AB4-0441BB51ECF4 Q40488508-0841CB8D-9364-4E33-BED3-3F7724F90327 Q40579950-BC903BB2-F723-40B5-AD40-15486A9DB371 Q41912194-FD0D7352-FF11-43A4-A81C-BED30FF43835 Q45333355-A2D68A1D-A9F1-4CD3-B4F4-56618BF6CF48 Q48632489-577BA719-A226-4EAB-AEA0-82F148A821CF Q52639097-2D1F655F-60D5-4386-91B6-1639A59A1661 Q53055140-FB6F0CCE-B21E-43A0-AF0B-43CCE6A12BEF Q57272563-A303F8FA-B174-4955-BD0D-00C9B64F5B94 Q58762125-678B8A00-BEB1-4AB9-9FA9-4CE8F2A2FDDE

P2860

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

http://www.wikidata.org/entity/Q28530421

description

2004 nî lūn-bûn

@nan

2004 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2004 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2004年の論文

@ja

2004年論文

@yue

2004年論文

@zh-hant

2004年論文

@zh-hk

2004年論文

@zh-mo

2004年論文

@zh-tw

2004年论文

@wuu

name

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@ast

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@en

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@nl

type

label

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@ast

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@en

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@nl

prefLabel

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@ast

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@en

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@nl

P1433

Q28530421-925A183C-F3BF-406C-B1E1-1E404C85B114

P1476

Q28530421-7A3BA659-BE89-4829-B8FD-50C6D4ED8521

P2093

Q28530421-12ABB851-32A9-4C6D-8F10-752818C51B3F

Q28530421-1C533EAF-C2F7-467D-BEE3-8F37FB98BD4C

Q28530421-920B36F8-7D18-47E7-AA21-29F50C028907

Q28530421-A620AACC-9231-401E-A267-3B0322B3E7D1

Q28530421-B088A56F-109C-4955-AF53-59331C3C4723

Q28530421-B23CDF10-B8D9-4925-AFB8-0CF320E26922

Q28530421-B46373CE-6F23-42E1-9154-9FF7CF2CB001

Q28530421-F35DF9FC-8756-45B1-8C8F-9DF40E418B2F

Q28530421-F80F7FCE-AF94-4099-B74D-E6F97C0F72DD

P2860

Q28530421-06B3E98A-5A15-47DE-983B-02E3022B3E4B

Q28530421-1FDA00EE-9B10-4D77-85BC-453A0231792E

Q28530421-27DB291D-AD25-4660-A2B7-0B1C9B6335BD

Q28530421-33EE20B2-A2EF-4DC5-BEA7-35518BCF281C

Q28530421-3FBC322A-0438-40A1-A7E0-FAF5D1DE6632

Q28530421-471C172B-DDD5-4E36-B0D6-2346E20732AF

Q28530421-66B6502C-A2F6-4F19-869E-624033CEDE10

Q28530421-74235806-A241-4710-B603-28E0C525B1CC

Q28530421-861949B1-4B06-49F8-A057-3A9C93F7DADB

Q28530421-8F3C3159-E86B-4866-B7DE-04A6092CD173

P304

Q28530421-E71204AF-2DAA-44E5-8F3E-BADDDBC5D170

P31

Q28530421-9B364CB2-22D4-4B28-9F4B-B663F541762A

P356

Q28530421-CD39BDA1-DDD3-4D3D-A7FF-7FC23DA6C485

P433

Q28530421-35D0CCBB-DEE5-47A0-8680-D3B05D12F134

P478

Q28530421-56E44038-B6BA-4093-9DDF-29344D88EBBC

P50

Q28530421-2ABEA708-D2D4-4639-A253-229C09A3F39B

Q28530421-61090de4-44b7-6e20-a22e-223672c27a4b

P577

Q28530421-B86590A6-7E41-4EE4-81E6-9EC4DDDEE5E5

P698

Q28530421-ABAD7558-B241-4B52-BCD4-8C327A071327

P356

P1433

Genes, Chromosomes and Cancer

P1476

CDK4is a probable target gene in a novel amplicon at 12q13.3-q14.1 in lung cancer

@en

P2093

Aki Väyrynen

http://www.w3.org/2001/XMLSchema#string

Harriet Wikman

http://www.w3.org/2001/XMLSchema#string

Kaisa Salmenkivi

http://www.w3.org/2001/XMLSchema#string

Katri Vainio-Siukola

http://www.w3.org/2001/XMLSchema#string

Kirsti Husgafvel-Pursiainen

http://www.w3.org/2001/XMLSchema#string

Maija Wolf

http://www.w3.org/2001/XMLSchema#string

Sakari Knuutila

http://www.w3.org/2001/XMLSchema#string

Sisko Anttila

http://www.w3.org/2001/XMLSchema#string

Sonata Jarmalaite

http://www.w3.org/2001/XMLSchema#string

P2860

Cloning and expression of mitochondrial translational elongation factor Ts from bovine and human liver

PIKE-A is amplified in human cancers and prevents apoptosis by up-regulating Akt

Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II

Molecular analysis of METTL1, a novel human methyltransferase-like gene with a high degree of phylogenetic conservation.

Dedifferentiation of a well-differentiated liposarcoma to a highly malignant metastatic osteosarcoma: amplification of 12q14 at all stages and gain of 1q22-q24 associated with metastases.

Enhanced malignant tumorigenesis in Cdk4 transgenic mice.

25-hydroxyvitamin D-1alpha-hydroxylase in normal and malignant colon tissue.

Glutathione S-transferases and aromatic DNA adducts in smokers' bronchoalveolar macrophages.

Increased expression of the 25-hydroxyvitamin D(3)-1alpha-hydroxylase gene in alveolar macrophages of patients with lung cancer.

Aberrant p16 promoter methylation in smokers and former smokers with nonsmall cell lung cancer.

P304

193-199

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1002/GCC.20122

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

42

http://www.w3.org/2001/XMLSchema#string

P50

Anne Kallioniemi

P577

2004-11-12T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

15543620

http://www.w3.org/2001/XMLSchema#string